Welcome Guest | Register / Login

Global IVIG Market Report: 2013 Edition

1. Overview    

1.1 Components of Blood Plasma    
1.2 Collection and Extraction of Plasma    
1.2.1 Plasma Collection    
1.2.2 Plasma Extraction    
1.2.3 Plasma Fractionation Yield    
1.3 Immunoglobulins: Intravenous immunoglobulin (IVIG)
1.3.1 IVIG’s Action Mechanism    
1.3.2 IVIG Dosage and Administration    

2. Market Size    

2.1 Global Blood Plasma Market
-Market Value
-Market Segmentation

2.2 Global IVIG Market
-Market Value
-Demand & Supply
-Regional Breakdown

2.2.1 IVIG Market of the US    
-Market Value
-Price Trend

3. Market Dynamics    

3.1 Industry Trends and Developments

3.1.1 Reimbursement    

3.2 Growth Drivers    

3.2.1 Rising Healthcare Expenditure
3.2.2 Higher Spending on Medicines    
3.2.3 Rising Demand for Better Healthcare Options    
3.2.4 Launch of NMEs (New Molecular Entities)    

3.3 Challenges    

3.3.1 Increasing Regulation in Plasma-collection Industry
3.3.2 Mounting Price Pressure    
3.3.3 Constrained Plasma Fractionation Capacity
3.3.4 Misdiagnosis of the Disease    

4. Competitive Landscape    

4.1 Immunoglobulins’ Market Contention
4.1.1 IVIG Market of Europe    
4.1.2 IVIG Market of North America    
4.1.3 IVIG Market of the US    

5. Company Profiles    

5.1 Baxter International Inc.    

5.1.1 Business Overview    
5.1.2 Financial Overview    
5.1.3 Business Strategies    
-Advancing the Core Portfolio Globally
-Expansion of Product Portfolio

5.2 Grifols    

5.2.1 Business Overview
5.2.2 Financial Overview    
5.2.3 Business Strategies
-Expansion in Other Regions
-Growth through Acquisitions

5.3 CSL Limited    

5.3.1 Business Overview    
5.3.2 Financial Overview    
5.3.3 Business Strategies    
-Focus on R&D
-Expanding Product Portfolio

6. Market Outlook    

6.1 Market Forecast    
6.2 Forecast Methodology    
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis    
6.2.3 Regression Analysis

List of Charts

Plasma Extraction from Donated Blood (Recovered Plasma)
Plasmapheresis (Source Plasma)
Global Blood Plasma Market (2000-2011)
Global Plasma Market Share by Product (2011)
Global IVIG Market Size (2004-2012)
Global IVIG Demand and Supply (2007-2012E)
IVIG Market Volume by Region (2005, 2008 and 2011)
Global IVIG Market Share by Geography (2011)
IVIG Use by Indication
Sales of IVIG in the US (2001-2012)
Lyophilised and Liquid IVIG Average Pricing in the US (March 2007-March 2013)
Global Healthcare Spending (2005-2015E)
Global Spending on Medicines (2006-2016E)
Global Spending on Medicine Share by Region (2006-2016E)
The US Spending on Medicine (2007-2016E)
Japan’s Spending on Medicine (2007-2016E)
Biotechnology Therapeutics Under Development (2011)
Global Plasma Market Share by Company (2011)
Global IVIG Market Share (2012)
Pricing of Leading IVIG Products (June 2009-June 2013)
Capacity Expansion Plans of the Key Industry Players (2012 and 2016E)
Europe’s IVIG Market Share (2011)
North America’s IVIG Market Share (2011)
The US IVIG Market (2011)
The US IG Sales Share by Value (2012)
Baxter’s Revenue by Business Segments (2012)
Baxter’s Revenues and Net Income (2008-2012)
Grifols Revenue Share by Business Segments (2012)
Grifols’ Revenues & Net Profit (2008-2012)
CSL’s Revenue Share by Major Products (2011-12)
CSL’s Revenues and Net Profit (2008/09-2011/12)
Global IVIG Market Forecast (2011-2015F)

List of Tables

Constituents of Blood Plasma
Recovered plasma vs. Source plasma
Output per Liter of Plasma
Breakdown of US IVIG usage by patient share (%) and volume share (%) by indication
Breakdown of US SCIG and IVIG usage by volume share (FY12)
US Centre for Medicare and Medicaid (CMS) Reimbursement
Patients Worldwide Waiting for Better Treatment Options (2011)
Global Availability of NMEs (2011)
IVIG Product Characteristics
Dependent & Independent Variables (2007-2011)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Why http://www.marketreportsonline.com/
Published By :Koncept Analytics